Monitor the closing of the AMS acquisition and the integration execution. The mandatory redemption clause on $450 million of notes if the deal fails by June 2027 creates a binary catalyst — a failed deal would trigger a large cash outflow but reduce leverage. Watch for any regulatory or shareholder hurdles to the AMS deal.
Price Chart
Executive Summary
H.B. Fuller commenced a $950 million private offering of senior unsecured notes due 2034 to fund the acquisition of Advanced Medical Solutions Group plc (AMS), repay existing borrowings, and redeem its 4.000% notes due February 2027. Pro forma financials show the combined company would have generated $3.87 billion in net revenue and $713 million in Adjusted EBITDA for the twelve months ended August 29, 2026, with a net total leverage ratio of 4.2x.
Key Facts
- H.B. Fuller commenced a $950 million aggregate principal amount offering of senior unsecured notes due 2034.
- Proceeds will fund the acquisition of Advanced Medical Solutions Group plc (AMS), repay borrowings under the credit agreement, redeem the 4.000% notes due February 15, 2027, and for general corporate purposes.
- If the AMS acquisition is not consummated by June 25, 2027 (or the cooperation agreement is terminated), H.B. Fuller must redeem $450 million of the notes at 100% of the issue price plus accrued interest.
- Pro forma combined net revenue for the twelve months ended August 29, 2026: $3.867 billion.
- Pro forma combined Adjusted EBITDA for the twelve months ended August 29, 2026: $713.5 million.
- Pro forma net total leverage ratio: 4.2x; pro forma interest coverage ratio: 3.3x.
- Pro forma net income attributable to FUL/AMS: $100.3 million.
Financial Impact
The $950 million notes offering funds a transformative acquisition (AMS) and refinances near-term debt, increasing leverage to 4.2x net debt/EBITDA but adding $313 million in AMS revenue and $69 million in AMS EBITDA to the combined entity.
Risk Factors
- Acquisition of AMS may not close by the June 25, 2027 outside date, triggering mandatory redemption of $450 million of notes.
- Pro forma net total leverage of 4.2x is elevated; any earnings shortfall could pressure debt service capacity.
- Integration risks combining AMS's UK-based operations and converting IFRS financials to U.S. GAAP.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-032108 |
| Document: ful20261005d_8k.htm | 0001437749-26-032108 |
| Document: 0001437749-26-032108-index-headers.html | 0001437749-26-032108 |
| Document: 0001437749-26-032108-index.html | 0001437749-26-032108 |
| Document: 0001437749-26-032108.txt | 0001437749-26-032108 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 8-K | $50.89 | awaiting T+5 | — | $49.55 (−2.63%) |
Oct 19, 2026 8d ago | 8-K | $51.06 $49.13 | ▼ −3.78% | ▼ −3.63% | $49.55 (−2.96%) |
Oct 9, 2026 18d ago | 8-K | $49.56 $51.32 | ▲ +3.55% | ▲ +5.52% | $49.55 (−0.02%) |
Oct 6, 2026 21d ago | 8-K | $50.63 $50.44 | ▼ −0.38% | ▼ −0.24% | $49.55 (−2.13%) |
Oct 1, 2026 26d ago | Insider Cluster | $50.23 $50.44 | ▲ +0.42% | ▼ −0.88% | $49.55 (−1.35%) |
Oct 1, 2026 26d ago | Insider Cluster | $50.23 $50.44 | ▲ +0.42% | ▼ −0.88% | $49.55 (−1.35%) |
Sep 30, 2026 27d ago | Insider Cluster | $49.47 $49.91 | ▲ +0.89% | ▼ −1.02% | $49.55 (+0.16%) |
Sep 28, 2026 29d ago | 8-K | $49.37 $50.44 | ▲ +2.17% | ▲ +0.96% | $49.55 (+0.36%) |
Sep 24, 2026 4w ago | 8-K | $50.00 $50.23 | ▲ +0.46% | ▲ +0.88% | $49.55 (−0.90%) |
Jul 20, 2026 14w ago | 8-K | $55.43 $55.70 | ▲ +0.49% | ▲ +0.91% | $49.55 (−10.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers